What is MedX Health Corp?
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally.
MDXHF · Verdict
Limited reward · high risk
MDXHF's standout is valuation; volatility and balance sheet weigh on the picture.
Based on 88% data coverage
MDXHF · Verdict
P/E 22.8×
Weak vs peers
Current ratio 0.10
-746% net margin · 0% ROE
Rev -4.5% CAGR · earnings -11.8%
-513% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 24.65M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.